PCP
OMCL icon

Perbak Capital Partners’s Omnicell OMCL Stock Holding History

Perbak Capital Partners’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,827
Closed -$1.24M – 292
2025
Q3 		$1.24M Buy
40,827
+14,573
+56% +$448K 0.22% 90
2025
Q2 		$772K Buy
26,254
+16,332
+165% +$488K 0.17% 115
2025
Q1 		$347K Buy
+9,922
New +$393K 0.26% 78

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Perbak Capital Partners's OMCL Position: Q4 2025 in Review

Perbak Capital Partners sold out of Omnicell (OMCL) in Q4 2025, closing a stake of 40,827 shares — an estimated $1.24M sold.

Perbak Capital Partners first reported a position in OMCL in Q1 2025 and held it in 3 quarters. The position peaked at $1.24M in Q3 2025. 262 funds tracked by Wall St. Rank hold OMCL as of Q4 2025.

  • Perbak Capital Partners reported no remaining Omnicell position as of Q4 2025 after selling out during the quarter.
  • Perbak Capital Partners sold 40,827 Omnicell shares in Q4 2025, an estimated $1.24M.
  • Perbak Capital Partners first reported a position in Omnicell in Q1 2025 and held it in 3 quarters.
  • Perbak Capital Partners's Omnicell position peaked at $1.24M in Q3 2025.
  • 262 funds tracked by Wall St. Rank held Omnicell as of Q4 2025.

Based on Perbak Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.